… Although chromium supplementation was associated with decrease of FBG levels in diabetic
patients [1], in the present study CrPic supplementation failed to affect the blood glucose …

… of the eight clinical trials included in this systematic review are shown. These clinical trials are
… The use of chromium picolinate supplementation as a toxic and carcinogenic agent due to …

… In contrast, in the clinical trial study by Farrokhian and colleagues, 12 weeks of chromium
picolinate supplementation of 200 µg per day in 64 diabetic patients with CHD led to a …

… randomized clinical trials investigating the effect of chromium … Chromium picolinate
supplementation resulted in a significant … found in diabetic patients with 200 mcg/day Cr picolinate …

… while the subjects were ingesting chromium picolinate. Chromium supplementation did not
… the subjects (healthy subjects, diabetic patients, patients with metabolic syndrome, impaired …

… Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients
with type 2 diabetes: a randomized clinical study. Journal of Trace Elements in Medicine …

… of chromium picolinate supplementation on reducing the risk of insulin resistance and type 2
diabetes … on glycemic control in patients with type 2 diabetes: a randomized clinical study. J …

… some clinical trials of chromium have performed on its use. Thus, we conducted this systematic
review and … supplementation in diabetes mellitus revealed a considerable reduction in …

… clinical trials reported favorable effects of 12 weeks interventions of brewer's yeast (42 μg
Chromium) [35] and 200 μg of chromium picolinate [46,49] … levels in diabetic patients [81]. This …

… “clinical trials” OR “cross-over Studies” … chromium picolinate and elemental supplement for
less and equal than 12 weeks and 200 μg/d for duration and dose, respectively, and diabetics …